Ulifloxacin

• CAT Number: R013785
• CAS Number: 112984-60-8
• Molecular Formula: C16H16FN3O3S
• Molecular Weight: 349.38
• Purity: ≥95%
• Synonyms: 6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid; AF 3013; NAD 394; NM 394; ?
• Target: Bacterial
• Storage: Store at RT
• IUPAC Name: 6-fluoro-1-methyl-4-oxo-7-piperazin-1-yl-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
• InChI: InChI=1S/C16H16FN3O3S/c1-8-20-11-7-12(19-4-2-18-3-5-19)10(17)6-9(11)14(21)13(16(22)23)15(20)24-8/h6-8,18H,2-5H2,1H3,(H,22,23)
• InChIKey: SUXQDLLXIBLQHW-UHFFFAOYSA-N
• SMILES: CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCNCC4

Ulifloxacin（Cat No.:R013785）is a fluoroquinolone antibiotic belonging to the fourth generation of quinolone drugs. It exhibits broad-spectrum antibacterial activity by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and repair. Structurally, ulifloxacin features a fluoroquinolone core with substitutions that enhance potency and tissue penetration. It is the active metabolite of prulifloxacin, a prodrug used orally for treating urinary tract infections and respiratory infections. Ulifloxacin is known for its improved pharmacokinetics, including good bioavailability and stability, making it effective against both Gram-positive and Gram-negative bacterial pathogens.